Connect
MJA
MJA

A hormonal male contraceptive: from wish to reality

David J Handelsman
Med J Aust 2002; 176 (5): . || doi: 10.5694/j.1326-5377.2002.tb04372.x
Published online: 4 March 2002

In a rejoinder to Benjamin Franklin's observation that nothing is certain in life bar death and taxes, people's fondest wishes seem to be to live forever and pay no tax. The timely and provocative study of Weston et al in this issue of the Journal (page 208),1 reporting high acceptability of a hormonal male contraceptive among new fathers, prompts a reflection on wishful thinking, as such a new contraceptive remains unavailable. In some respects, contraception is closer to a consumer lifestyle choice than a conventional medical treatment, as illustrated by the impact of media-inspired contraceptive "scares" that have led to panic-driven abandonment of contraception and subsequent unwanted pregnancies.2


  • ANZAC Research Institute, Concord Hospital, Concord, NSW.


Correspondence: djh@anzac.edu.au

  • 1. Weston GC, Schlipalius ML, Bhuinneain MN, Vollenhoven BJ. Will Australian men use male hormonal contraception? A survey of a postpartum population. Med J Aust 2002; 176: 208-210. <eMJA full text>
  • 2. Benagiano G, Primiero FM. Safety of modern oral contraception: the options for women: lessons to be learned. Hum Reprod Update 1999; 5: 633-638.
  • 3. Martin CW, Anderson RA, Cheng L, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 2000; 15: 637-645.
  • 4. Glasier AF, Anakwe R, Everington D, et al. Would women trust their partners to use a male pill? Hum Reprod 2000; 15: 646-649.
  • 5. Ringheim K. Factors that determine prevalence of use of contraceptive methods for men. Stud Fam Plann 1993; 24: 87-99.
  • 6. Ringheim K. Evidence for the acceptability of an injectable hormonal method for men. Int Fam Plann Perspect 1995; 21: 75-80.
  • 7. Handelsman DJ. Male contraception. In: DeGroot LJ, editor. Endocrinology. Philadelphia: W B Saunders, 2001: 2344-2349.
  • 8. United Nations. Levels and trends of contraceptive use as assessed in 1998. New York: Department of International Economic and Social Affairs, 2001.
  • 9. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955-959.
  • 10. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821-829.
  • 11. Liskin L, Benoit E, Blackburn R. Vasectomy: new opportunities. Baltimore: Population Information Program, Johns Hopkins University, 1992.
  • 12. Sneyd MJ, Cox B, Paul C, Skegg DC. High prevalence of vasectomy in New Zealand. Contraception 2001; 64: 155-159.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.